Trade Clariane SE - CLARI CFD

Add to favourite

1.56

3.11%

0.07

Low: 1.56

High: 1.6

Market Trading Hours* (UTC) Opens on Monday at 07:00

Mon - Fri: 07:00 - 15:30

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.07

Long position overnight fee

-0.022102%

Short position overnight fee

-0.000121%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

EUR

Margin

Stock exchange

France

Commission on trade

*Information provided by Capital.com

Clariane SE ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	1.61
Open*	1.56
1-Year Change*	-78.89%
Day's Range*	1.56 - 1.6
52 wk Range	2.03-10.12
Average Volume (10 days)	418.92K
Average Volume (3 months)	16.89M
Market Cap	229.68M
P/E Ratio	7.42
Shares Outstanding	106.20M
Revenue	4.73B
EPS	0.29
Dividend (Yield %)	11.6279
Beta	0.86
Next Earnings Date	Feb 28, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 18, 2024	1.61	0.02	1.26%	1.59	1.64	1.56
Apr 17, 2024	1.56	-0.03	-1.89%	1.59	1.60	1.52
Apr 16, 2024	1.61	0.06	3.87%	1.55	1.62	1.55
Apr 15, 2024	1.60	0.01	0.63%	1.59	1.62	1.58
Apr 12, 2024	1.65	0.02	1.23%	1.63	1.75	1.63
Apr 11, 2024	1.66	-0.02	-1.19%	1.68	1.73	1.66
Apr 10, 2024	1.72	-0.03	-1.71%	1.75	1.84	1.70
Apr 9, 2024	1.77	0.04	2.31%	1.73	1.83	1.73
Apr 8, 2024	1.77	-0.02	-1.12%	1.79	1.79	1.69
Apr 5, 2024	1.70	0.02	1.19%	1.68	1.75	1.64
Apr 4, 2024	1.74	-0.09	-4.92%	1.83	1.87	1.71
Apr 3, 2024	1.80	0.13	7.78%	1.67	1.85	1.65
Apr 2, 2024	1.63	0.17	11.64%	1.46	1.69	1.46
Mar 28, 2024	1.46	0.06	4.29%	1.40	1.52	1.39
Mar 27, 2024	1.43	0.02	1.42%	1.41	1.45	1.36
Mar 26, 2024	1.42	0.07	5.19%	1.35	1.47	1.30
Mar 25, 2024	1.37	-0.05	-3.52%	1.42	1.43	1.37
Mar 22, 2024	1.45	0.03	2.11%	1.42	1.49	1.42
Mar 21, 2024	1.44	-0.04	-2.70%	1.48	1.51	1.41
Mar 20, 2024	1.51	0.14	10.22%	1.37	1.57	1.35

Clariane SE Events

Time (UTC)	Country	Event
Thursday, April 25, 2024
Time (UTC) 15:40	Country FR	Event Q1 2024 Clariane SE Corporate Sales Release Q1 2024 Clariane SE Corporate Sales Release Forecast - Previous -
Thursday, June 13, 2024
Time (UTC) 10:59	Country FR	Event Clariane SE Annual Shareholders Meeting Clariane SE Annual Shareholders Meeting Forecast - Previous -
Friday, June 14, 2024
Time (UTC) 10:59	Country FR	Event Korian SE Annual Shareholders Meeting Korian SE Annual Shareholders Meeting Forecast - Previous -
Sunday, June 30, 2024
Time (UTC) 15:40	Country FR	Event Half Year 2024 Clariane SE Corporate Sales Release Half Year 2024 Clariane SE Corporate Sales Release Forecast - Previous -
Tuesday, July 30, 2024
Time (UTC) 10:59	Country FR	Event Half Year 2024 Clariane SE Earnings Release Half Year 2024 Clariane SE Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	4438.3	4137.31	3772.91	3612.5	3333.79
Revenue	4438.3	4137.31	3772.91	3612.5	3333.79
Cost of Revenue, Total	351.936	309.313	297.045	276.743	265.142
Gross Profit	4086.36	3828	3475.86	3335.76	3068.65
Total Operating Expense	4165.77	3795.52	3507	3253.93	3034.52
Selling/General/Admin. Expenses, Total	3215.53	2999.07	2725.17	2460.22	2590.62
Depreciation / Amortization	654.882	615.757	556.681	510.641	163.298
Interest Expense (Income) - Net Operating			14.21	-2.191	7.282
Unusual Expense (Income)	61.939	41.708	5.975	2.149	1.141
Other Operating Expenses, Total	-118.524	-170.329	-92.075	6.372	7.041
Operating Income	272.528	341.792	265.904	358.571	299.262
Interest Income (Expense), Net Non-Operating	-195.9	-190.308	-194.955	-164.066	-100.043
Other, Net	-18.693	-18.172	-10.892	-18.994	-21.581
Net Income Before Taxes	57.935	133.312	60.057	175.511	177.638
Net Income After Taxes	45.773	121.893	42.881	116.225	125.032
Minority Interest	-9.278	-21.772	-2.702	-1.544	-1.899
Net Income Before Extra. Items	35.741	99.883	39.403	114.681	123.133
Net Income	22.06	91.115	39.403	114.681	123.133
Income Available to Common Excl. Extra. Items	35.741	99.883	39.402	114.681	123.133
Income Available to Common Incl. Extra. Items	22.06	91.115	39.402	114.681	123.133
Diluted Net Income	22.06	91.115	39.402	114.681	123.133
Diluted Weighted Average Shares	120.457	105.294	105.78	96.3027	95.2298
Diluted EPS Excluding Extraordinary Items	0.29671	0.94861	0.37249	1.19084	1.29301
Dividends per Share - Common Stock Primary Issue	0.25	0.35	0.3	0	0.55419
Diluted Normalized EPS	0.70297	1.31079	0.413	1.20562	1.30144
Total Adjustments to Net Income			-0.001	0
Equity In Affiliates	-0.754	-0.238	-0.776
Total Extraordinary Items	-13.681	-8.768

	Jun 2023	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Total revenue	2453.72	2272.84	2165.46	2130.84	2006.47
Revenue	2453.72	2272.84	2165.46	2130.84	2006.47
Cost of Revenue, Total	205.134	183.462	168.474	148.203	161.11
Gross Profit	2248.59	2089.38	1996.98	1982.63	1845.36
Total Operating Expense	2332.19	2131.31	2034.46	1925.98	1867.33
Selling/General/Admin. Expenses, Total	1812.18	1645.32	1570.22	1520.05	1476.4
Depreciation / Amortization	337.482	332.677	322.205	307.094	309.073
Interest Expense (Income) - Net Operating		-4.511	4.511	-5.905	5.905
Unusual Expense (Income)	22.076	29.302	32.636	54.692	6.798
Other Operating Expenses, Total	-44.683	-54.935	-63.588	-98.151	-91.959
Operating Income	121.529	141.528	131	204.854	139.146
Interest Income (Expense), Net Non-Operating	-129.047	-100.656	-95.244	-95.443	-93.244
Other, Net	27.031	-9.748	-8.945	-11.374	-8.419
Net Income Before Taxes	19.513	31.124	26.811	98.037	37.483
Net Income After Taxes	14.739	25.243	20.53	77.87	45.524
Minority Interest	-7.033	-2.419	-6.859	-9.188	-12.584
Equity In Affiliates	0.115	0.021	-0.775	0.566	-0.804
Net Income Before Extra. Items	7.821	22.845	12.896	69.248	32.136
Net Income	1.208	9.164	12.896	60.48	32.136
Income Available to Common Excl. Extra. Items	7.821	22.845	12.896	69.248	32.136
Income Available to Common Incl. Extra. Items	1.208	9.164	12.896	60.48	32.136
Diluted Net Income	1.208	9.164	12.896	60.48	32.136
Diluted Weighted Average Shares	106.204	105.713	119.153	105.55	121.605
Diluted EPS Excluding Extraordinary Items	0.07364	0.2161	0.10823	0.65607	0.26427
Dividends per Share - Common Stock Primary Issue	0	0.25	0	0.35	0
Diluted Normalized EPS	0.23065	0.44091	0.31796	1.06764	0.3006
Total Extraordinary Items	-6.613	-13.681		-8.768

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	1788.08	2128.19	1882.71	903.232	998.964
Cash and Short Term Investments	736.567	1217.54	1162.81	346.201	551.518
Cash	721.792	1072.23	938.778	289.686	457.41
Cash & Equivalents	11.918	142.337	220.331	55.1	92.951
Short Term Investments	2.857	2.971	3.7	1.415	1.157
Total Receivables, Net	792.556	781.302	623.515	465.973	387.722
Accounts Receivable - Trade, Net	440.368	364.674	315.301	284.047	235.611
Total Inventory	28.623	28.236	36.186	33.909	17.113
Prepaid Expenses	95.62	93.774	57.985	52.529	39.398
Other Current Assets, Total	134.717	7.343	2.216	4.62	3.213
Total Assets	14573.6	14308.1	13197.3	10938.2	7623.46
Property/Plant/Equipment, Total - Net	7004.44	6547.54	6102.12	5472.58	2292.43
Property/Plant/Equipment, Total - Gross	8774.43	8203.02	7645.13	6788.14	3670.81
Accumulated Depreciation, Total	-1769.99	-1655.48	-1543.01	-1315.56	-1378.38
Goodwill, Net	3237.26	3213.84	2905.6	2504.15	2311.82
Intangibles, Net	2256.71	2180.72	2157.75	1943.86	1822.82
Long Term Investments	70.474	62.139	69.962	38.152	57.296
Other Long Term Assets, Total	216.6	175.643	79.181	76.259	140.133
Total Current Liabilities	2822.88	2406.51	2614.24	1929.52	1392.2
Accounts Payable	733.354	609.166	453.62	369.942	315.111
Accrued Expenses	452.752	406.46	404.201	385.565	305.09
Notes Payable/Short Term Debt	0.546	0	11.849	7.583	7.757
Current Port. of LT Debt/Capital Leases	1317.83	1040.84	1128.54	545.536	273.182
Other Current Liabilities, Total	318.404	350.043	616.034	620.896	491.06
Total Liabilities	11034.3	10814.8	10040.3	8380.05	5067.28
Total Long Term Debt	6930.77	7186.73	6481.38	5721.32	2859.62
Long Term Debt	3559.36	3761.48	3130.5	2405.89	2859.62
Deferred Income Tax	603.68	584.317	605.204	534.627	583.287
Minority Interest	328.655	271.131	165.566	11.449	11.814
Other Liabilities, Total	348.352	366.103	173.956	183.138	220.355
Total Equity	3539.22	3493.29	3156.98	2558.19	2556.19
Common Stock	532.526	527.968	525.191	413.641	409.882
Additional Paid-In Capital	1205.66	1196.25	1182.78	902.503	881.765
Retained Earnings (Accumulated Deficit)	1801.04	1769.07	1449.01	1242.04	1264.54
Other Equity, Total		-0.001		0.001
Total Liabilities & Shareholders’ Equity	14573.6	14308.1	13197.3	10938.2	7623.46
Total Common Shares Outstanding	106.204	105.084	104.991	89.5428	88.7024
Capital Lease Obligations	3371.41	3425.25	3350.88	3315.42

	Jun 2023	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Total Current Assets	1643.16	1788.08	1950.58	2128.19	1910.52
Cash and Short Term Investments	377.232	736.567	888.333	1214.56	1000.95
Cash	373.088	721.792	855.935	1072.23	890.387
Cash & Equivalents	1.919	11.918	28.462	142.337	110.565
Total Receivables, Net	1047.35	792.556	831.787	878.047	861.673
Accounts Receivable - Trade, Net	492.563	440.368	406.364	364.674	377.971
Total Inventory	29.873	28.623	26.467	28.236	46.213
Other Current Assets, Total	52.266	134.717	86.392	7.343	1.678
Total Assets	14766.2	14573.6	14334.6	14308.1	13737.7
Property/Plant/Equipment, Total - Net	7037.13	7004.44	6713.83	6547.54	6209
Property/Plant/Equipment, Total - Gross	8904.11	8774.43	8422.48	8203.02	7771.05
Accumulated Depreciation, Total	-1866.98	-1769.99	-1708.64	-1655.48	-1562.05
Goodwill, Net	3346.59	3237.26	3231.05	3213.84	3115.48
Intangibles, Net	2320.33	2256.71	2192.73	2180.72	2162.35
Long Term Investments	164.582	70.474	59.397	62.139	71.564
Other Long Term Assets, Total	254.437	216.6	186.97	175.643	268.791
Total Current Liabilities	3365.49	2822.88	2228.12	2406.51	2547.47
Accounts Payable	687.035	733.354	605.227	499.717	466.177
Notes Payable/Short Term Debt	0.325	0.546	-177.848	0	84.883
Current Port. of LT Debt/Capital Leases	1758.96	1317.83	952.31	1040.84	1210.65
Other Current Liabilities, Total	368.991	318.404	392.866	865.952	785.763
Total Liabilities	11270.2	11034.3	10852.9	10814.8	10316.2
Total Long Term Debt	6552.05	6930.77	7391.21	7186.73	6651.5
Long Term Debt	2986.9	3559.36	3960.8	3761.48	3301.03
Capital Lease Obligations	3565.15	3371.41	3430.41	3425.25	3350.47
Deferred Income Tax	627.502	603.68	631.068	584.317	613.582
Minority Interest	372.545	328.655	289.3	271.131	184.433
Other Liabilities, Total	352.573	348.352	313.205	366.103	319.171
Total Equity	3496.07	3539.22	3481.67	3493.29	3421.55
Common Stock	532.526	532.526	528.093	527.968	525.281
Additional Paid-In Capital	1205.66	1205.66	1196.25	1196.25	1182.78
Retained Earnings (Accumulated Deficit)	1757.89	1801.04	1757.32	1769.07	1713.49
Other Equity, Total				-0.001	-0.001
Total Liabilities & Shareholders’ Equity	14766.2	14573.6	14334.6	14308.1	13737.7
Total Common Shares Outstanding	106.204	106.204	105.109	105.084	105.009
Short Term Investments	2.225	2.857	3.936
Prepaid Expenses	136.442	95.62	117.606
Accrued Expenses	550.18	452.752	455.562

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	45.02	121.655	42.104	116.224	125.032
Cash From Operating Activities	861.576	840.036	794.926	765.714	377.272
Cash From Operating Activities	617.158	612.719	524.721	460.33	142.34
Deferred Taxes					-8.21
Non-Cash Items	251.37	248.273	281.377	251.793	0.893
Cash Interest Paid	180.039	190.336	194.874	179.729	102.019
Changes in Working Capital	-51.972	-142.611	-53.276	-62.633	117.217
Cash From Investing Activities	-770.264	-825.284	-1097.11	-636.247	-363.341
Capital Expenditures	-622.201	-528.911	-520.103	-326.271	-264.596
Other Investing Cash Flow Items, Total	-148.063	-296.373	-577.005	-309.976	-98.745
Cash From Financing Activities	-550.131	31.384	1112.24	-334.858	24.87
Financing Cash Flow Items	-214.625	6.705	-183.202	-187.216	-110.337
Total Cash Dividends Paid	-57.826	-36.436		-24.657	-24.865
Issuance (Retirement) of Stock, Net	29.836	92.946	639.529	1.134	0.564
Issuance (Retirement) of Debt, Net	-307.516	-31.831	655.913	-124.119	159.508
Net Change in Cash	-464.725	50.305	810.058	-205.391	38.801
Cash Taxes Paid	87.368	44.755	66.269	59.379
Foreign Exchange Effects	-5.906	4.169

	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Net income/Starting Line	45.02	19.755	121.655	44.72
Cash From Operating Activities	861.576	368.608	840.036	314.766
Cash From Operating Activities	617.158	309.265	612.719	288.371
Non-Cash Items	251.37	125.624	248.273	135.576
Cash Taxes Paid	87.368	42.535	44.755	15.037
Cash Interest Paid	180.039	94.411	190.336	97.812
Changes in Working Capital	-51.972	-86.036	-142.611	-153.901
Cash From Investing Activities	-770.264	-427.817	-825.284	-553.743
Capital Expenditures	-622.201	-272.687	-528.911	-252.521
Other Investing Cash Flow Items, Total	-148.063	-155.13	-296.373	-301.222
Cash From Financing Activities	-550.131	-250.899	31.384	71.658
Financing Cash Flow Items	-214.625	-119.257	6.705	130.955
Total Cash Dividends Paid	-57.826	-8.879	-36.436	-7.287
Issuance (Retirement) of Stock, Net	29.836	-28.865	92.946	-0.49
Issuance (Retirement) of Debt, Net	-307.516	-93.898	-31.831	-51.52
Foreign Exchange Effects	-5.906	-3.727	4.169	0.027
Net Change in Cash	-464.725	-313.835	50.305	-167.292

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Korian Medica Company profile

About Korian SA

Korian SA, formerly Korian Medica SA, is a France-based company that operates healthcare facilities and medical establishments. The Company's holdings include residential centers for the elderly, offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Furthermore, the Company offers hospitalization at home, which avoids or shortens the hospitalization process; and home nursing services, which allows the care prescribes by a doctor at home. Korian-Medicas' establishments are located in France, Italy and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Korian SA revenues increased 14% to EUR4.31B. Net income applicable to common stockholders increased from EUR39.4M to EUR94.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items increased from EUR0.43 to EUR0.90.

Equity composition

06/2010, Stock Dividend, 0.038192 new share for every 1 share held. 10/2020, Rights Issue, 4 new shares for every 15 shares held @ EUR18.1 (Factor: 1.08266).

Industry:

Healthcare Facilities & Services (NEC)

21 - 25 rue Balzac
PARIS
ILE-DE-FRANCE 75008
FR

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024